Novel pegylated interferon‐β as strong suppressor of the malignant ascites in a peritoneal metastasis model of human cancer-Reference-Cited by-同舟云学术

Novel pegylated interferon‐β as strong suppressor of the malignant ascites in a peritoneal metastasis model of human cancer

Published:2017-04 Issue:4 Volume:108 Page:581-589
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Iwamura Tomokatsu¹,Narumi Hideki¹,Suzuki Tomohiko¹,Yanai Hideyuki²³,Mori Katsuyuki¹,Yamashita Koji⁴,Tsushima Yoshiaki⁴,Asano Tomomi¹,Izawa Akiko¹,Momen Shinobu¹,Nishimura Kazumi¹,Tsuchiyama Hiromi¹,Uchida Masashi¹,Yamashita Yuji⁴,Okano Kiyoshi¹,Taniguchi Tadatsugu²³

Affiliation:

1. Pharmaceutical Research Laboratory Toray Industries Kamakura Kanagawa Japan

2. Department of Molecular Immunology Institute of Industrial Science The University of Tokyo Tokyo Japan

3. Max Planck‐The University of Tokyo Center for Integrative Inflammology Tokyo Japan

4. Pharmaceuticals Technical Development Department Toray Industries Kamakura KanagawaJapan

Funder

Japan Science and Technology Agency

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13176

Reference40 articles.

1. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures

2. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research

3. A weak signal for strong responses: interferon-alpha/beta revisited

4. Antitumour actions of interferons: implications for cancer therapy

5. Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer;EMBO Molecular Medicine;2024-01-18

2. The role of interferons in ovarian cancer progression: Hinderer or promoter?;Frontiers in Immunology;2022-12-21

3. Molecular biology and immunology of gastric cancer peritoneal metastasis;Translational Gastroenterology and Hepatology;2020-10

4. Type I Interferons: History and Perspectives as Immunotherapeutic Agents Against Cancer;Cancer Immunology;2020-09-25

5. Interferons: role in cancer therapy;Immunotherapy;2020-08